Home > Income Statement > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Consolidated Net Profit

    Back to Income Statement
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹556 Cr₹3,593 Cr₹-71 Cr₹-203 Cr₹-460 Cr

What is the latest Consolidated Net Profit of STRIDES PHARMA SCIENCE ?

The latest Consolidated Net Profit ratio of STRIDES PHARMA SCIENCE is ₹556 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹556 Cr
Mar2025₹3,593 Cr
Mar2024₹-71 Cr
Mar2023₹-203 Cr
Mar2022₹-460 Cr

How is Consolidated Net Profit of STRIDES PHARMA SCIENCE Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹556 Cr
-84.52
Mar2025 ₹3,593 Cr
Positive
Mar2024 ₹-71 Cr
Negative
Mar2023 ₹-203 Cr
Negative
Mar2022 ₹-460 Cr -

Compare Consolidated Net Profit of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹10,306.6 Cr -7.1% 9.1% 38.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,679.0 Cr -1.8% -7% 14.3% Stock Analytics
DIVIS LABORATORIES ₹246,408.0 Cr -3.4% 0.4% 58.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹182,634.0 Cr -2.7% -3.6% 36% Stock Analytics
CIPLA ₹109,063.0 Cr -3.9% -4.7% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,166.0 Cr 3% 6.1% -3.8% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-7.1%

9.1%

38.5%

SENSEX

-3.1%

-6.2%

-11.7%


You may also like the below Video Courses